loading
前日終値:
$3.85
開ける:
$3.84
24時間の取引高:
98,308
Relative Volume:
0.28
時価総額:
$230.00M
収益:
-
当期純損益:
$-40.33M
株価収益率:
-0.6675
EPS:
-5.97
ネットキャッシュフロー:
$-39.53M
1週間 パフォーマンス:
-3.51%
1か月 パフォーマンス:
+31.52%
6か月 パフォーマンス:
+28.96%
1年 パフォーマンス:
+232.08%
1日の値動き範囲:
Value
$3.81
$4.04
1週間の範囲:
Value
$3.76
$4.17
52週間の値動き範囲:
Value
$1.1099
$5.54

Eledon Pharmaceuticals Inc Stock (ELDN) Company Profile

Name
名前
Eledon Pharmaceuticals Inc
Name
セクター
Healthcare (1195)
Name
電話
949-238-8090
Name
住所
19800 MACARTHUR BLVD., IRVINE
Name
職員
20
Name
Twitter
Name
次回の収益日
2024-11-07
Name
最新のSEC提出書
Name
ELDN's Discussions on Twitter

ELDN を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
ELDN 3.99 230.00M 0 -40.33M -39.53M -5.97
VRTX 450.01 115.43B 10.63B -479.80M -1.35B 13.33
REGN 746.02 82.04B 13.85B 4.65B 3.32B 35.06
ARGX 594.70 35.30B 1.86B -40.29M -1.28B -4.16
ALNY 245.85 32.04B 2.09B -332.26M 16.06M -4.14
BNTX 107.66 24.89B 3.30B -501.07M 1.03B 11.54

Eledon Pharmaceuticals Inc Stock (ELDN) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2022-05-13 再開されました Cantor Fitzgerald Overweight
2021-03-23 開始されました Cantor Fitzgerald Overweight

Eledon Pharmaceuticals Inc (ELDN) 最新ニュース

pulisher
Nov 20, 2024

Eledon Pharmaceuticals retains shares target, Buy rating on clinical trial progress - Investing.com Nigeria

Nov 20, 2024
pulisher
Nov 20, 2024

HC Wainwright Reaffirms "Buy" Rating for Eledon Pharmaceuticals (NASDAQ:ELDN) - MarketBeat

Nov 20, 2024
pulisher
Nov 18, 2024

FY2024 EPS Estimates for ELDN Boosted by Cantor Fitzgerald - MarketBeat

Nov 18, 2024
pulisher
Nov 15, 2024

FY2024 Earnings Forecast for ELDN Issued By Lifesci Capital - MarketBeat

Nov 15, 2024
pulisher
Nov 15, 2024

ARMISTICE CAPITAL, LLC Acquires Shares in Eledon Pharmaceuticals Inc - GuruFocus.com

Nov 15, 2024
pulisher
Nov 14, 2024

Eledon Pharmaceuticals, Inc.'s (NASDAQ:ELDN) market cap dropped US$48m last week; individual investors who hold 57% were hit as were institutions - Yahoo Finance

Nov 14, 2024
pulisher
Nov 14, 2024

Institutions along with individual investors who hold considerable shares inEledon Pharmaceuticals, Inc. (NASDAQ:ELDN) come under pressure; lose 16% of holdings value - Simply Wall St

Nov 14, 2024
pulisher
Nov 14, 2024

Hopkins alum leads Eledon Pharmaceuticals in breakthrough diabetes tegoprubart treatment - Johns Hopkins News-Letter

Nov 14, 2024
pulisher
Nov 12, 2024

Eledon Pharmaceuticals Reports Strong Q3 2024 Results - TipRanks

Nov 12, 2024
pulisher
Nov 12, 2024

Eledon Pharmaceuticals Announces Recent Business Highlights and Third Quarter 2024 Financial Results - The Manila Times

Nov 12, 2024
pulisher
Nov 12, 2024

Eledon Pharma Surges: $85M Offering, Strong Trial Results Drive Q3 Success | ELDN Stock | ELDN Stock News - StockTitan

Nov 12, 2024
pulisher
Nov 08, 2024

Amyotrophic Lateral Sclerosis Treatment Market to Grow by USD 663.7 Million from 2024-2028, as Rising Incidence Drives Demand with AI Redefining Market LandscapeTechnavio - The Malaysian Reserve

Nov 08, 2024
pulisher
Nov 08, 2024

Midday Stock Roundup: Indie Semiconductor Up 43% - Orange County Business Journal

Nov 08, 2024
pulisher
Nov 06, 2024

Eledon Pharmaceuticals to Participate in Guggenheim Securities Inaugural Healthcare Innovation Conference - The Manila Times

Nov 06, 2024
pulisher
Nov 06, 2024

Eledon Pharmaceuticals to Participate in Guggenheim Securities Inaugural Healthcare Innovation - The Bakersfield Californian

Nov 06, 2024
pulisher
Nov 06, 2024

Eledon Pharmaceuticals CEO to Present at Guggenheim's First Healthcare Innovation Conference | ELDN Stock News - StockTitan

Nov 06, 2024
pulisher
Nov 05, 2024

RA Capital Management, L.P. Acquires New Stake in Eledon Pharmac - GuruFocus.com

Nov 05, 2024
pulisher
Nov 01, 2024

Biotechnology Value Fund L P's Strategic Acquisition in Eledon P - GuruFocus.com

Nov 01, 2024
pulisher
Oct 31, 2024

ELDN stock touches 52-week high at $4.13 amid robust gains - Investing.com Australia

Oct 31, 2024
pulisher
Oct 30, 2024

ELDN stock touches 52-week high at $4.13 amid robust gains By Investing.com - Investing.com South Africa

Oct 30, 2024
pulisher
Oct 30, 2024

SEC Form 424B5 filed by Eledon Pharmaceuticals Inc. - Quantisnow

Oct 30, 2024
pulisher
Oct 30, 2024

Eledon drug helps transplants 'cure' type 1 diabetes - pharmaphorum

Oct 30, 2024
pulisher
Oct 29, 2024

Eledon Pharmaceuticals sets terms for $85 million stock offering By Investing.com - Investing.com South Africa

Oct 29, 2024
pulisher
Oct 29, 2024

Eledon: Changing Scope Of Immunosuppressive Drug Space With Tegoprubart (ELDN) - Seeking Alpha

Oct 29, 2024
pulisher
Oct 29, 2024

Eledon Pharmaceuticals Shares Hit 52-Week High After Positive Trial Data - MarketWatch

Oct 29, 2024
pulisher
Oct 29, 2024

Promising results for diabetes treatment with new drug By Investing.com - Investing.com Australia

Oct 29, 2024
pulisher
Oct 29, 2024

Eledon Pharmaceuticals sets terms for $85 million stock offering - Investing.com India

Oct 29, 2024
pulisher
Oct 29, 2024

Eledon Pharmaceuticals Announces Positive Initial Data from Subjects with Type 1 Diabetes Treated with Tegoprubart as Part of an Immunosuppression Regimen Following Islet Transplantation in Investigator-Initiated Trial at UChicago Medicine - The Manila Times

Oct 29, 2024
pulisher
Oct 29, 2024

Promising results for diabetes treatment with new drug - Investing.com India

Oct 29, 2024
pulisher
Oct 29, 2024

Eledon Pharmaceuticals Announces Pricing of $85 Million - GlobeNewswire

Oct 29, 2024
pulisher
Oct 29, 2024

Eledon Pharmaceuticals Announces Pricing of $85 Million Underwritten Offering of Common Stock and Pre-Funded Warrants - StockTitan

Oct 29, 2024
pulisher
Oct 26, 2024

Algorae Pharmaceuticals Plans Major Securities Issuance - MSN

Oct 26, 2024
pulisher
Oct 23, 2024

ELDN stock soars to 52-week high, touches $3.35 amid surge - Investing.com

Oct 23, 2024
pulisher
Oct 04, 2024

Financial Analysis: Eledon Pharmaceuticals (NASDAQ:ELDN) & ABVC BioPharma (NASDAQ:ABVC) - Defense World

Oct 04, 2024
pulisher
Oct 03, 2024

IgA nephropathy Clinical Trials 2024 (Updated): FDA Approvals, - openPR

Oct 03, 2024
pulisher
Oct 03, 2024

IgA nephropathy Clinical Trials 2024 (Updated): FDA Approvals, Pipeline, Medication, Therapies, Treatment Market and Companies by DelveInsight - Barchart

Oct 03, 2024
pulisher
Oct 01, 2024

Eledon Pharmaceuticals completes $4 million equity sale - Investing.com India

Oct 01, 2024
pulisher
Oct 01, 2024

Eledon Pharmaceuticals completes $4 million equity sale By Investing.com - Investing.com South Africa

Oct 01, 2024
pulisher
Oct 01, 2024

Nantahala Capital Management LLC Invests $1.58 Million in Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) - Defense World

Oct 01, 2024
pulisher
Oct 01, 2024

Nantahala Capital Management LLC Acquires New Position in Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) - MarketBeat

Oct 01, 2024
pulisher
Sep 28, 2024

Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) Short Interest Update - MarketBeat

Sep 28, 2024
pulisher
Sep 27, 2024

Midday Stock Roundup: STAAR Surgical CO. Shares Surge 22% - Orange County Business Journal

Sep 27, 2024
pulisher
Sep 20, 2024

Eledon Pharmaceuticals initiates $75 million stock sale agreement By Investing.com - Investing.com Australia

Sep 20, 2024
pulisher
Sep 20, 2024

Eledon Pharmaceuticals initiates $75 million stock sale agreement - Investing.com

Sep 20, 2024
pulisher
Sep 11, 2024

Eledon Pharmaceuticals to Present at the Cantor Global Healthcare Conference - GlobeNewswire

Sep 11, 2024
pulisher
Sep 04, 2024

ELDNEledon Pharmaceuticals, Inc. Latest Stock News & Market Updates - StockTitan

Sep 04, 2024
pulisher
Sep 04, 2024

Eledon Announces Completion of Enrollment in Phase 2 BESTOW - GlobeNewswire

Sep 04, 2024

Eledon Pharmaceuticals Inc (ELDN) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$18.98
price up icon 1.80%
$70.68
price down icon 0.42%
$38.38
price up icon 3.49%
$369.83
price up icon 1.48%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
大文字化:     |  ボリューム (24 時間):